Scientific Posters

Proveris Studies

Stay up to date with the latest Proveris presentations at industry conferences and scientific meetings.

All Nasal Device Testing pMDI Device Testing

Using a predictive design of experiments (DoE) approach to investigate the in vitro performance sensitivity of an OTC multi-dose nasal spray

Poster presented at the Novel Nasal Formulation and Delivery Summit; 2023 May 17 – 18, San Diego, California, USA. Proveris® Scientific Corporation, Hudson MA USA

A comparison of spray characteristics of P-134A and low GWP P-152A pMDIs with and without ethanol

pMDI Device Testing

Poster presented at RDD Europe 2023 Conference; 2023 May 2 – 5, Antibes (Nice), France. 1Proveris® Scientific Corporation, Hudson MA USA, 2Koura, Thornton Science Park, Cheshire, UK

The Effect of Ethanol Concentration on pMDI Evaporation Fraction

pMDI Device Testing

The Effect of Ethanol Concentration on pMDI Evaporation Fraction Linda Liao1, Ameet Sule2, Ben Okorodudu1, Ian Flaherty1, Heli Chauhan1, Andrew Newman2, Sunita Sule2, Richard Turner2. Poster presented at Digital RDD 2020; 2020 April 26 – 30; Digital Conference.1Proveris® Scientific Corporation,

A Novel Characterization of Emitted Aerosol Velocity Profiles From Metered Dose & Soft Mist Inhalers

pMDI Device Testing

A novel characterization of emitted aerosol velocity profiles from metered dose and soft mist inhalers Linda (Lingzhi) Liao, Karina Ramos, and Dino Farina. Poster presented at Drug Delivery to the Lungs 2019; 2019 Dec 11 – 13; Edinburgh, Scotland BACKGROUND:

Characterization of an HFA pressurized metered dose inhaler using a novel, Quality by Design (QbD) approach

pMDI Device Testing

Characterization of an HFA pressurized metered dose inhaler using a novel, Quality by Design (QbD) approach D. Farina. Poster presented at AAPS Annual Meeting and Exposition 2008; 2008 Nov 16 – 20; Atlanta, GA. INTRODUCTION: The purpose of this presentation

A shaking control space study for a Fluticasone/Salmeterol metered dose inhaler based on spray pattern analysis

pMDI Device Testing

A shaking control space study for a Fluticasone/Salmeterol metered dose inhaler based on spray pattern analysis D. Farina, D., Z. Pitluk, S. Pallas. Poster presented at AAPS Annual Meeting and Exposition 2013; 2013 Nov 10 – 14; San Antonio, TX.

Comparison of impaction and non-impaction methods for measuring spray patterns from MDIs

pMDI Device Testing

Comparison of impaction and non-impaction methods for measuring spray patterns from MDIs Pitluk, Z., S. Pallas, J. Graaf, D. Farina. Poster presented at The Aerosol Society Conference, Drug Delivery to the Lungs 24; 2013 Dec 11 – 13; Edinburgh, Scotland.

How critical quality attributes and process variables drive the in-vitro performance of pMDIs: new technologies and methods

pMDI Device Testing

How critical quality attributes and process variables drive the in-vitro performance of pMDIs: new technologies & methods Poster presented at Inhalation Asia Conference 2015. INTRODUCTION: Few published sources exist to help guide pMDI formulation and device development that incorporate an

Understanding the importance and effects of shaking on pMDI performance

pMDI Device Testing

Understanding the importance and effects of shaking on pMDI performance Newcomb, A., D. Farina. Poster presented at The Aerosol Society Conference, Drug Delivery to the Lungs 26; 2015 Dec 9 – 11; Edinburgh, Scotland. INTRODUCTION: This paper explores how a

Unit dose nasal sprays: method effects of setting stroke length on spray characteristics

Nasal Device Testing

Unit dose nasal sprays: method effects of setting stroke length on spray characteristics Poster presented at AAPS Annual Meeting and Exposition 2015. Shaw, C., Smith, M., Richiuso A., Kulkarni V. – DPT Laboratories Ltd., Newcomb A. – Proveris Scientific Corp.

Determination of the influencing factors on in vitro performance of a marketed OTC nasal spray product using a Quality by Design (QbD) and Design of Experiments (DOE) approach

Nasal Device Testing

Determination of the influencing factors on in vitro performance of a marketed OTC nasal spray product using a Quality by Design (QbD) and Design of Experiments (DOE) approach Poster presented at Respiratory Drug Delivery Conference Asia 2014. Farina DJ, Pitluk

Using a predictive design of experiments approach to investigate the in vitro performance sensitivity of a unit dose nasal spray

Nasal Device Testing

Using a predictive design of experiments approach to investigate the in vitro performance sensitivity of a unit dose nasal spray Poster presented at Respiratory Drug Delivery 2016 Shaw CJ, Smith M, Newcomb A, Farina DJ, Kulkarni VS; Respiratory Drug Delivery

Impact of actuator design on multi-dose nasal spray characteristics

Nasal Device Testing

Impact of actuator design on multi-dose nasal spray characteristics Poster presented at Respiratory Drug Delivery Conference 2018. Chauhan H, Liu-Cordero S, Liao L, Werbeck J; Respiratory Drug Delivery 2018. Volume 2, 2018: 497-502. INTRODUCTION: Developing a successful multi-dose nasal spray

Evaluating spray characteristics of multi-dose nasal spray devices across different actuator designs

Nasal Device Testing

Evaluating spray characteristics of multi-dose nasal spray devices across different actuator designs Poster presented at Respiratory Drug Delivery Conference Asia 2018. Chauhan H, Liu-Cordero S, Jones D, Okorodudu B; RDD Asia 2018. Volume 1, 2018: 199-204. INTRODUCTION: This paper explores

Proveris Studies